2017 Bloom Burton & Co. Healthcare Investor Conference
May 1-2, 2017

Sheraton Centre Toronto Hotel - 123 Queen St W.

Photo Gallery

2017 Agenda Booklet

THE CONFERENCE

2017 KEYNOTE SPEAKERS AND PANELISTS

Ron Cohen

Chairman, Biotechnology Industry Organization; President and CEO, Acorda Therapeutics

Ron Cohen, M.D. is President, CEO and founder of Acorda Therapeutics, Inc., a public biotechnology company developing therapies for disorders of the nervous system, including multiple sclerosis, Parkinson’s disease and migraine.

Dr. Cohen previously was a principal in the startup and an officer of Advanced Tissue Sciences, Inc., a biotechnology company engaged in the growth of human organ tissues for transplantation uses. He is Chair of the Board of the Biotechnology Innovation Organization (BIO), and a Director on the Board of Directors of VBL Therapeutics. He previously served as a Director on the Board of Dyax Corp. until its acquisition in 2016. He also previously served as Chair of the Emerging Companies Section of the BIO Board and as Director and Chair of the New York Biotechnology Association (NYBA). Dr. Cohen is a member the Columbia-Presbyterian Health Sciences Advisory Council and was awarded Columbia University’s Alumni Medal for Distinguished Service.

Acorda Therapeutics has been recognized as one of the Best Companies to Work for in New York State seven years in a row (2011-2017), among the Fortune 100 Best Medium-Size Workplaces the U.S. (2017), and among the Fortune 100 Best Workplaces for Women (2016-2017), Millennials (2017) and Baby Boomers (2017).

Dr. Cohen is a recipient of the NY CEO Lifetime Achievement Award and the Ernst & Young Entrepreneur of the Year Award for the New York Metropolitan Region. He was named Neuroinvestment’s CEO of the Year and is an inductee of the National Spinal Cord Injury Association’s “Spinal Cord Injury Hall of Fame.” Dr. Cohen received the Burke Award from Burke Rehabilitation Hospital for his contributions to helping people with disabilities gain independence. He has been recognized by the New York Biotechnology Association as the NYBA “The Cures Start Here” Business Leader of the Year, by the Westchester County Association as its Lead-ership Award recipient, by Life Science Leader Magazine as True Life Sci-ence Leader of the year, and by PharmaVOICE Magazine as one of the 100 Most Inspirational People in the Biopharmaceutical Industry.

Dr. Cohen received his B.A. degree with honors in Psychology from Princeton University, and his M.D. from the Columbia College of Physicians & Surgeons. He completed a residency in Internal Medicine at the University of Virginia Medical Center, and is Board Certified in Internal Medicine.

Avik Roy

President, Foundation for Research on Equal Opportunity; Managing Partner, Roy Healthcare Research

Avik Roy is one of North America’s leading experts on healthcare policy. His reform proposal, Transcending Obamacare: A Patient-Centered Plan for Near-Universal Coverage and Permanent Fiscal Solvency, is one of the plans most influential in Washington as Republicans debate how to replace the Affordable Care Act.

Mr. Roy has advised a number of the 2016 presidential candidates on healthcare and other areas of public policy, including Marco Rubio and Rick Perry. In 2012, Mr. Roy served as healthcare policy advisor to Mitt Romney; in that role, he helped develop Romney’s agenda on healthcare and entitlement reform for the 2012 presidential campaign. He also served on Romney’s presidential transition team, in which capacity he was responsible for recommending candidates for the major healthcare positions in the federal government, including at HHS, CMS, and the FDA.

Mr. Roy is the President of the Foundation for Research on Equal Opportunity (FREOPP.org) and the Managing Partner at Roy Healthcare Research, LLC, which provides proprietary healthcare investment and policy research to institutional investors and stakeholders. Roy’s work has been praised widely on both the right and the left. National Review has called him one of America’s “sharpest policy minds,” while the New York Times’ Paul Krugman described him as man of “personal and moral courage.”

Roy’s writing has also appeared in The Wall Street Journal, The New York Times, The Washington Post, USA Today, The Atlantic, National Review, The Weekly Standard, and National Affairs, among other publications.
He is a frequent guest on television news programs, including appearances on Fox News, Fox Business, CNN, NBC, MSNBC, CNBC, Bloomberg, CBS, PBS, and HBO. He serves on the advisory board of the National Institute for Health Care Management, is a Senior Advisor to the Bipartisan Policy Center, and co-chaired the Fixing Veterans Health Care Policy Taskforce.

From 2011 to 2016, Mr. Roy was a senior fellow at the Manhattan Institute for Policy Research, where he published research on healthcare policy, on topics such as the Affordable Care Act, Medicare, Medicaid, and FDA reform. He is the author of “The Apothecary,” an influential blog on healthcare policy at Forbes, where Roy also serves as Opinion Editor.

Prior to his career in healthcare policy, Mr. Roy spent a dozen years on the Wall Street buy side as a health care analyst and portfolio manager, at institutions such as Bain Capital and J.P. Morgan.